Distribution of Biorad Bioplex Reagents and Consumables for Laboratory Tests.
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
It is the intent of the Pathology Laboratory Medicine of the Seattle VAMC, Department of Veterans Affairs (herein afterwards referred to as Seattle VAMC) to establish a contract for the distribution of BioRad BioPlex laboratory reagents. The Government will award contract to a single Contractor for Automated Immunoassay Instrumentation. Contractor agrees to the following terms of the contract exclusively with the Seattle VAMC listed by Attachment and awarded in the final contract. The instrument shall be able to perform immunoassays for ANA Screens, Syphilis IgG and RPR, Measles/Mumps/Rubella/Varicella, Herpes Simplex virus (HSV) antibodies, Cytomegalovirus (CMV) antibodies, Epstein-Barr Virus (EBV) antibodies, Vasculitis Panel, Anti-CCP Panel, Celiac Panels, Antiphospholipid Panels, HIV Antibody Panel and Toxoplasma. Vendor will provide methodology for differentiation the of HIV 1 and HIV 2. Additional tests/reagents/instrumentation may be added to the contract as new technology becomes available on the market and added to the contract.